These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 37702446)

  • 21. EBV infection and MSI status significantly influence the clinical outcomes of gastric cancer patients.
    Shen H; Zhong M; Wang W; Liao P; Yin X; Rotroff D; Knepper TC; Mcleod HL; Zhou C; Xie S; Li W; Xu B; He Y
    Clin Chim Acta; 2017 Aug; 471():216-221. PubMed ID: 28601671
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Microsatellite instability and Epstein-Barr virus combined with PD-L1 could serve as a potential strategy for predicting the prognosis and efficacy of postoperative chemotherapy in gastric cancer.
    Yang N; Wu Y; Jin M; Jia Z; Wang Y; Cao D; Qin L; Wang X; Zheng M; Cao X; Jiang J
    PeerJ; 2021; 9():e11481. PubMed ID: 34046266
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genomically Stable Gastric Cancer Characterized by Hypomethylation in Wnt Signal Cascade.
    Toshima T; Tanioka H; Mori Y; Tanaka T; Yasui K; Kimura K; Umeda Y; Fujiwara T; Nyuya A; Yano S; Nagasaka T
    Oncology; 2023; 101(2):105-116. PubMed ID: 36244328
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pattern of recurrence and overall survival in esophagogastric cancer after perioperative FLOT and clinical outcomes in MSI-H population: the PROSECCO Study.
    Nappo F; Fornaro L; Pompella L; Catanese S; Lavacchi D; Spallanzani A; Cappetta A; Puzzoni M; Murgioni S; Barsotti G; Tirino G; Pellino A; Vivaldi C; Strippoli A; Aprile G; Di Donato S; Mazza E; Prisciandaro M; Antonuzzo L; Zagonel V; Cascinu S; De Vita F; Lonardi S
    J Cancer Res Clin Oncol; 2023 Aug; 149(9):6601-6611. PubMed ID: 36795195
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High levels of tumor cell-intrinsic STING signaling are associated with increased infiltration of CD8
    Kanoda R; Nakajima S; Fukai S; Saito M; Saito K; Suzuki H; Kikuchi T; Nirei A; Okayama H; Mimura K; Hanayama H; Sakamoto W; Momma T; Saze Z; Kono K
    Sci Rep; 2024 Sep; 14(1):20859. PubMed ID: 39242811
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Elevated microsatellite instability at selected tetranucleotide (EMAST) repeats in gastric cancer: a distinct microsatellite instability type with potential clinical impact?
    Herz AL; Wisser S; Kohlruss M; Slotta-Huspenina J; Jesinghaus M; Grosser B; Steiger K; Novotny A; Hapfelmeier A; Schmidt T; Gaida MM; Weichert W; Keller G
    J Pathol Clin Res; 2022 May; 8(3):233-244. PubMed ID: 35099128
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Microsatellite instability and Epstein-Barr virus infection in gastric remnant cancers.
    Chang MS; Lee JH; Kim JP; Kim HS; Lee HS; Kim CW; Kim YI; Kim WH
    Pathol Int; 2000 Jun; 50(6):486-92. PubMed ID: 10886725
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of Micro Satellite Instability and Mismatch Repair Status in Different Solid Tumors: A Multicenter Analysis in a Real World Setting.
    Malapelle U; Parente P; Pepe F; De Luca C; Pisapia P; Sgariglia R; Nacchio M; Gragnano G; Russo G; Conticelli F; Bellevicine C; Vigliar E; Iaccarino A; Covelli C; Balistreri M; Clemente C; Perrone G; Danza A; Scaramuzzi F; Fassan M; Troncone G; Graziano P
    Cells; 2021 Jul; 10(8):. PubMed ID: 34440647
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preservation of Epstein-Barr virus status and mismatch repair protein status along the metastatic course of gastric cancer.
    Dislich B; Blaser N; Berger MD; Gloor B; Langer R
    Histopathology; 2020 Apr; 76(5):740-747. PubMed ID: 31898331
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic implication of molecular subtypes and response to neoadjuvant chemotherapy in 760 gastric carcinomas: role of Epstein-Barr virus infection and high- and low-microsatellite instability.
    Kohlruss M; Grosser B; Krenauer M; Slotta-Huspenina J; Jesinghaus M; Blank S; Novotny A; Reiche M; Schmidt T; Ismani L; Hapfelmeier A; Mathias D; Meyer P; Gaida MM; Bauer L; Ott K; Weichert W; Keller G
    J Pathol Clin Res; 2019 Oct; 5(4):227-239. PubMed ID: 31206244
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinicopathological features of PD-L1 protein expression, EBV positivity, and MSI status in patients with advanced gastric and esophagogastric junction adenocarcinoma in Japan.
    Yoshida T; Ogura G; Tanabe M; Hayashi T; Ohbayashi C; Azuma M; Kunisaki C; Akazawa Y; Ozawa S; Matsumoto S; Suzuki T; Mitoro A; Fukunaga T; Shimizu A; Fujimoto G; Yao T
    Cancer Biol Ther; 2022 Dec; 23(1):191-200. PubMed ID: 35220884
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detecting immunotherapy-sensitive subtype in gastric cancer using histologic image-based deep learning.
    Hinata M; Ushiku T
    Sci Rep; 2021 Nov; 11(1):22636. PubMed ID: 34811485
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Is Adjuvant Chemotherapy Necessary for Patients with Deficient Mismatch Repair Gastric Cancer?-Autophagy Inhibition Matches the Mismatched.
    Tsai CY; Lin TA; Huang SC; Hsu JT; Yeh CN; Chen TC; Chiu CT; Chen JS; Yeh TS
    Oncologist; 2020 Jul; 25(7):e1021-e1030. PubMed ID: 32058649
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Impact of Mismatch Repair Status on Prognosis of Patients With Gastric Cancer: A Multicenter Analysis.
    Guan WL; Ma Y; Cui YH; Liu TS; Zhang YQ; Zhou ZW; Xu JY; Yang LQ; Li JY; Sun YT; Xu RH; Wang FH; Qiu MZ
    Front Oncol; 2021; 11():712760. PubMed ID: 34900669
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular subtype switching in early-stage gastric cancers with multiple occurrences.
    Takaoka S; Hirotsu Y; Ohyama H; Mochizuki H; Amemiya K; Oyama T; Ashizawa H; Yoshimura D; Nakagomi K; Hosoda K; Suzuki Y; Kojima Y; Omata M
    J Gastroenterol; 2019 Aug; 54(8):674-686. PubMed ID: 30666417
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Abundant PD-L1 expression in Epstein-Barr Virus-infected gastric cancers.
    Derks S; Liao X; Chiaravalli AM; Xu X; Camargo MC; Solcia E; Sessa F; Fleitas T; Freeman GJ; Rodig SJ; Rabkin CS; Bass AJ
    Oncotarget; 2016 May; 7(22):32925-32. PubMed ID: 27147580
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alterations in the human epidermal growth factor receptor 2-phosphatidylinositol 3-kinase-v-Akt pathway in gastric cancer.
    Sukawa Y; Yamamoto H; Nosho K; Kunimoto H; Suzuki H; Adachi Y; Nakazawa M; Nobuoka T; Kawayama M; Mikami M; Matsuno T; Hasegawa T; Hirata K; Imai K; Shinomura Y
    World J Gastroenterol; 2012 Dec; 18(45):6577-86. PubMed ID: 23236232
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of mismatch repair or microsatellite status on the prognosis and efficacy to chemotherapy in metastatic colorectal cancer patients: A bi-institutional, propensity score-matched study.
    Yao YC; Jin Y; Lei XF; Wang ZX; Zhang DS; Wang FH; Li YH; Xu RH; Wang F
    J Cancer; 2022; 13(9):2912-2921. PubMed ID: 35912009
    [No Abstract]   [Full Text] [Related]  

  • 39. Adjuvant Chemotherapy for Gastric Cancer Patients with Mismatch Repair Deficiency or Microsatellite Instability: Systematic Review and Meta-Analysis.
    Nie RC; Chen GM; Yuan SQ; Kim JW; Zhou J; Nie M; Feng CY; Chen YB; Chen S; Zhou ZW; Wang Y; Li YF
    Ann Surg Oncol; 2022 Apr; 29(4):2324-2331. PubMed ID: 34796431
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epstein-Barr virus infection serves as an independent predictor of survival in patients with lymphoepithelioma-like gastric carcinoma.
    Min BH; Tae CH; Ahn SM; Kang SY; Woo SY; Kim S; Kim KM
    Gastric Cancer; 2016 Jul; 19(3):852-9. PubMed ID: 26265391
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.